Atrium Therapeutics, Inc.
RNA나스닥Pharmaceutical PreparationsUS미국
30일 공시 수
4건
최근 2026.11.02
90일 내부자 순매수
0원
변동 없음
보유 기관 수
—
준비 중
다음 예정 이벤트
—
준비 중
총 12건
- US미국주요사항·수시공시중요도 낮음어제8-K · Current report (Items 7.01, 8.01, 9.01)
Atrium Therapeutics, Inc.RNA
8-K · 2026.11.02 20:47 KST
- US미국주요사항·수시공시중요도 낮음7일 전8-K · Current report (Items 8.01, 9.01)
Atrium Therapeutics, Inc.RNA
8-K · 2026.10.27 21:55 KST
- US미국주요사항·수시공시중요도 낮음2026.10.09정정8-K/A · Current report (Items 8.01)
Atrium Therapeutics, Inc.RNA
8-K/A · 2026.10.09 19:17 KST
- US미국증자·자금조달중요도 높음2026.10.088-K · Current report (Items 1.01, 3.02, 8.01, 9.01)
Atrium Therapeutics, Inc.RNA
8-K · 2026.10.08 19:52 KST
- US미국임원·주요주주 소유중요도 낮음2026.09.224 · Statement of changes in beneficial ownership
Atrium Therapeutics, Inc.RNA
Form 4 · 2026.09.22
- US미국임원·주요주주 소유중요도 낮음2026.09.224 · Statement of changes in beneficial ownership
Atrium Therapeutics, Inc.RNA
Form 4 · 2026.09.22
- US미국임원·주요주주 소유중요도 낮음2026.09.224 · Statement of changes in beneficial ownership
Atrium Therapeutics, Inc.RNA
Form 4 · 2026.09.22
- US미국임원·주요주주 소유중요도 낮음2026.09.224 · Statement of changes in beneficial ownership
Atrium Therapeutics, Inc.RNA
Form 4 · 2026.09.22
- US미국임원·주요주주 소유중요도 낮음2026.09.224 · Statement of changes in beneficial ownership
Atrium Therapeutics, Inc.RNA
Form 4 · 2026.09.22
- US미국임원·주요주주 소유중요도 낮음2026.09.224 · Statement of changes in beneficial ownership
Atrium Therapeutics, Inc.RNA
Form 4 · 2026.09.22